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T cell receptor (TCR) microclusters form within seconds of T cell contact with supported 
planar bilayers containing intercellular adhesion molecule-1 and agonist major 
histocompatibility complex (MHC)–peptide complexes, and elevation of cytoplasmic Ca
 
2
 
 
 
 
is observed within seconds of the first detectable microclusters. At 0–30 s after contact, 
TCR microclusters are colocalized with activated forms of Lck, ZAP-70, and the linker for 
activation of T cells. By 2 min, activated kinases are reduced in the older central microclusters, 
but are abundant in younger peripheral microclusters. By 5 min, TCR in the central 
supramolecular activation cluster have reduced activated kinases, whereas faint peripheral 
TCR microclusters efficiently generated activated Lck and ZAP-70. TCR microcluster 
formation is resistant to inhibition by Src family kinase inhibitor PP2, but is abrogated by 
actin polymerization inhibitor latrunculin A. We propose that Src kinase–independent 
formation of TCR microclusters in response to agonist MHC–peptide provides an actin-
dependent scaffold for signal amplification.
 
T cell activation is dependent upon the inter-
action of T cell receptors with MHC–peptide
complexes in the interface between T cells
and APCs (1). Molecular rearrangements after
antigen recognition lead to the formation of
an organized immunologic synapse (IS) that
is characterized by a central cluster of T cell
receptors (central supramolecular activation
cluster [cSMAC]), which is surrounded by a
ring of adhesion molecules (peripheral SMAC
[pSMAC])
 
 
 
(2–4). Signaling is initiated before
the formation of the IS and can proceed in the
absence of IS formation (5–9). Furthermore,
the large central cluster of TCRs in the cSMAC
is a site where signals are down-regulated; this
suggests that T cell receptor clustering may
correspond to down-regulation, rather than
initiation phases of TCR signaling (6, 8). Before
IS formation, TCR microclusters form in the
interface using cell–cell and cell-supported
planar systems for studying the IS (10, 11).
TCR microclusters also are formed in the inter-
face between Jurkat T cells and glass substrates
that are coated directly with anti-CD3, but do
not translocate to form a cSMAC (12). These
studies predict that TCR microclusters will
initiate signaling through recruitment of tyrosine
kinases and adaptor molecules (13, 14). How-
ever, the kinetics of signaling and requirements
for formation of TCR microclusters in response
to agonist MHC–peptide is unknown.
 
RESULTS AND DISCUSSION
 
Imaging of T cell activation with supported
planar bilayers offers several advantages in spatial
and temporal resolution, sampling efficiency,
and control of conditions when compared
with cell–cell imaging (15). We demonstrated
previously that laterally mobile intercellular
adhesion molecule (ICAM)-1 and I-E
 
k
 
-moth
cytochrome 
 
c
 
 peptide 88–103 in supported
bilayers  induce the proliferation of antigen-
specific T cell blasts (5). In this system, previous
tracking of TCRs, using confocal microscopy,
and H57 Fab fragments prebound to the TCR
 
 
 
subunit, revealed that TCR/MHCp micro-
clusters form in the contact area between T
cells and supported planar bilayers, and, as the
cells spread on the substrate, accumulate at the
periphery (11). The microclusters move to
the center of the contact area to form the
cSMAC by 5 min. This is identical to the ki-
netics of microcluster formation and transloca-
tion in cell–cell systems (7, 10, 16). To study the
relationship of TCR microclusters to early T
cell signaling, we used in vitro activated AND
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TCR Tg T cells and supported planar bilayers containing
glycosylphosphatidyl inositol anchored ICAM-1 (ICAM-1–
GPI) and I-E
 
k
 
-GPI with moth cytochrome 
 
c
 
 peptide 88–103
(agonist MHCp) at 40 molecules/
 
 
 
m
 
2
 
. T cells formed mi-
croclusters on these bilayers with 
 
 
 
140 TCR each that are
readily detectable by wide-field fluorescence microscopy
(Fig. 1 A). We next determined the relationship of TCR
microcluster formation to cytoplasmic Ca
 
2
 
 
 
. We used a cy-
toplasmic dye, Fluo-LOJO, to measure relative Ca
 
2
 
 
 
 levels
based on increased fluorescence intensity in parallel with
Alexa 546-H57 Fab; through the objective, total internal re-
flection fluorescence microscopy (TIRFM) (17) was used to
detect even small TCR microclusters. TIRFM detects fluo-
rescence within 100–200 nm of the interface between the T
cells and the planar bilayers, and thus, provides very high lat-
eral and axial resolution at the cell–planar bilayer interface
(18). Images of Fluo-LOJO fluorescence and TCR fluores-
cence were acquired alternately with a delay of 1 s between
the TIRFM image of the TCR cluster and the image of cy-
toplasmic Ca
 
2
 
 
 
. As reported previously (19), T cells rested
on the bilayer for a few seconds before initiating contact for-
mation. During this time, the basal fluorescence of the indi-
Figure 1. Dynamic of TCR microclusters during formation of a 
mature IS. (A) A series of images of Alexa546-H57 Fab–labeled AND TCR 
Tg T cell blasts interacting with planar bilayer containing ICAM-1 and 
agonist MHCp at times indicated. Time is relative to first detected contact 
area. This sequence is representative of three experiments with at least 20 
cells observed in each. (B) Alexa546-H57 Fab and Fluo-LOJO dye–labeled 
AND TCR Tg T cell blasts interacting with planar bilayers containing ICAM-1 
and agonist MHCp at early times. TIRFM of Alexa546 anti-TCR to visualize 
microcluster formation (top row) and wide field image of Fluo-LOJO 
fluorescence 4  m above the contact plane indicates relative cytoplasmic 
Ca2  (bottom row). The TIRFM image was acquired 1 s before the Fluo-LOJO 
image. Representative of three experiments.
Figure 2. Relationship of pLck394, pZAP-70319, and pLAT191 to 
TCR microclusters during IS formation. Alexa546-H57 Fab–labeled 
AND TCR Tg T cells were incubated on bilayers containing ICAM-1 and 
MHCp. At different times after cell injection, the cells were fixed to 
yield contacts that formed between 0–0.5 min, 1–2 min, or 4–5 min. 
Cell were permeabilized and stained with antibodies to pLck394 (A), 
pZAP319 (B), and pLAT191 (C) followed by Alexa488-conjugated secondary 
antibodies. TCR- (red in overlay) and phosphoprotein-specific antibodies 
(green in overlay) were imaged by wide-field fluorescence microscopy. 
(D) Colocalization was quantified based on the Improvision colocalization 
algorithm (classifier threshold 1.5 ). Microclusters from at least 10 
contact areas were included for each data point. 
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vidual T cell was assessed. Small contacts with a single de-
tectable TCR microcluster remained in the basal range of
Fluo-LOJO fluorescence; however, contacts with two or
three TCR clusters consistently displayed elevated Fluo-
LOJO fluorescence (Fig. 1 B). There was a delay of 
 
 
 
5 s be-
tween the first detectable TCR microcluster and elevation
of cytoplasmic Ca
 
2
 
 
 
. On bilayers with ICAM-1 only Fluo-
LOJO fluorescence fluctuates in the basal region. Because of
its low K
 
Ca2
 
 
 
, Fluo-LOJO is sensitive to basal fluctuations in
cytoplasmic Ca
 
2
 
 
 
. Thus, T cell receptor signaling is initiated
well before complete spreading of the T cell, and appearance
of the first TCR microcluster precedes Ca
 
2
 
 
 
 signaling.
We next determined the relationship of microcluster for-
mation to activation of tyrosine kinases Lck and 
 
 
 
-associated
protein of 70 kD (ZAP-70) and the phosphorylation of the
adaptor molecule linker of activated T cells (LAT). AND
TCR Tg T cells were allowed to settle on bilayers contain-
ing ICAM-1 and agonist MHCp for 30 s, 2 min, or 5 min at
37
 
 
 
C; cells were fixed, permeabilized, and stained with affin-
ity-purified antibodies to phospho-Lck tyr 394 (pLck
 
394
 
) (6,
20), phospho–ZAP-70 tyr 319 (pZAP
 
319
 
) (21), or phospho-
LAT tyr 191 (pLAT
 
191
 
) (22). The antibody to pLck
 
394
 
weakly cross reacts with autophosphorylated Fyn (20). Con-
trols included the use of nonimmune species–matched IgG
and examination of specific fluorescence on ICAM-1 only
bilayers (unpublished data). At 30 s, there was a high degree
of colocalization of pLck
 
394
 
, pZAP
 
319
 
, and pLAT
 
191
 
 with
TCR microclusters (Fig. 2, A–C). Early central TCR mi-
croclusters often appeared to fuse together, but were still
functional (e.g., Fig. 2 A, 0–30 s). By 2 min, the TCR clus-
ters near the center of the contact retained pZAP
 
319
 
, but al-
ready showed lower levels of pLck
 
394
 
, whereas more periph-
eral TCR microclusters still were colocalized with pLck
 
394
 
and pZAP
 
319
 
. In addition to colocalizing with TCR micro-
clusters, pLck
 
394
 
 stained at a lower level in the peripheral re-
gion of the synapse just outside the pSMAC. By 5 min, the
cSMAC had formed and was largely devoid of pLck
 
394
 
,
pZAP
 
319
 
, and pLAT
 
191
 
. However, the periphery still con-
tained bright foci of all three phosphoproteins, even if TCR
microclusters could not be resolved clearly. Quantification
of colocalization of pLck
 
394
 
, pZAP
 
319
 
, and pLAT
 
191
 
 with the
visible TCR signal decreased over 5 min (Fig. 2 D). There-
fore, these signaling events in the periphery were not medi-
ated by the TCR, or TCR clusters were forming that were
not visible by wide-field fluorescence microscopy.
We used TIRFM to determine if we could identify
TCR microclusters in the periphery that would correspond
to the presence of pLck
 
394
 
 and pZAP
 
319
 
 at 5 min. TIRFM
revealed faint, but definitive, TCR clusters in the periphery
at 5 min, which colocalized with the pLck
 
394
 
 and pZAP
 
319
 
(Fig. 3, A and B). Thus, peripheral TCR microclusters un-
dergo a 10-fold decrease in intensity by 5 min, but are still
detected readily by TIRFM, although not by confocal or
wide-field fluorescence imaging because of interference
from out-of-focus fluorescence. TIRFM also increased the
sensitivity of detection of pLck
 
394
 
 and pZAP
 
319
 
 such that sig-
naling was detected at 5 min in the large central TCR clus-
ters. We quantified the “signaling efficiency” as the ratio of
the relevant phosphorylated kinase/TCR. At 5 min, the sig-
naling efficiency was 30-fold higher for pLck
 
394
 
 and pZAP
 
319
 
in peripheral clusters than in central clusters. Greater than
95% of pLck
 
394
 
 and pZAP
 
319
 
 was contained in peripheral
microclusters by 5 min.
We next determined whether early TCR microclusters
are formed as a consequence of signaling. PP2 is a potent in-
hibitor of T cell receptor signaling that inhibits all src family
kinases and some additional tyrosine kinases, and blocks
ZAP-70 recruitment to the activated TCR on anti-CD3
substrates (12, 23, 24). When T cells were pretreated with 20
 
 
 
M PP2 and exposed to the bilayers containing ICAM-1 and
agonist MHCp in the continued presence of the same con-
centration of PP2, AND TCR Tg T cells were able to form
TCR microclusters without elevation of cytoplasmic Ca
 
2
 
 
 
above the basal range (Fig. 4 A). The basal fluctuations in cy-
toplasmic Ca
 
2
 
 
 
 might mask signaling at the TCR, so we ad-
dressed this by directly examining the activation of Lck in the
presence of PP2. The amount of pLck
 
394
 
 in the contact was
reduced by 91% at 20 
 
 
 
M PP2 and by 
 
 
 
95% by 100 
 
 
 
M
PP2, yet TCR microclusters still formed at both concentra-
tions (Fig. 4 B). PP2 (10 
 
 
 
M) completely inhibited pSMAC
formation, reduced contact size as indicated by interference
Figure 3. Colocalization of pLck394 and pZAP319 with peripheral 
TCR microclusters in the IS. Cells were prepared exactly as for 4–5-min 
time point in Fig. 2, and then TCR (red in overlay) and the indicated phos-
phoprotein (green in overlay) were imaged by TIRFM for cells stained with 
pLck394 (A) and pZAP319 (B). Examples of locations where peripheral TCR 
clusters colocalize with active kinases are indicated with arrowheads; 
positions where the large central TCR clusters contained active kinases are 
indicted by an arrow. The dividing line between central and peripheral 
structures used for calculation of the signaling efficiency is indicated in 
the overlay by the dotted white line. Representative of three experiments. 
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reflection microscopy (IRM), and reduced adhesion by 40%
(Fig. 4 C). Thus, TCR microcluster formation was highly re-
sistant to inhibition by PP2 (10–100 
 
 
 
M) compared with
other down-stream effects of TCR signaling, but we cannot
rule out that residual pLck
 
394
 
 (
 
 
 
5%) in the TCR microclus-
ters may contribute to their formation. Although ZAP-70 is
not inhibited by PP2, its accumulation in TCR microclusters
was reduced similarly to Lck (unpublished data).
We next asked if TCR microcluster formation was de-
pendent upon actin cytoskeleton. The TCR is constitutively
linked to actin, and TCR signaling induces a dramatic re-
modeling of the actin cytoskeleton to form the IS (25, 26).
We used the actin monomer sequestering inhibitor latruncu-
lin A to treat T cells before their introduction into the sup-
ported planar bilayer containing ICAM-1 and agonist
MHCp. When T cells were pretreated with 1 
 
 
 
M latruncu-
lin A they did not form any TCR microclusters, nor was
there any evidence of TCR interaction with MHC–peptide
complexes in the interface (Fig. 4 C). 42% of the T cells
formed contact areas that were mediated by LFA-1–ICAM-1
interaction as demonstrated by ICAM-1 accumulation and
IRM visualization of the contact areas. This was consistent
with earlier studies that laterally mobile LFA-1 can engage
ICAM-1 in cytochalasin D–treated lymphocytes (27). Thus,
TCR microcluster formation requires participation of the
actin cytoskeleton.
This series of experiments suggests that TCR microclus-
ters are involved in early T cell signaling that is initiated by
agonist MHCp, and that a second wave of smaller TCR mi-
croclusters may contribute substantially to sustained signal-
ing. The formation of one to three TCR microclusters in
small nascent contact areas was contemporaneous with the
initiation of cytoplasmic Ca
 
2
 
 
 
 increase. However, we found
that signaling within the earliest TCR microclusters is tran-
sient and is stopped largely by 2–5 min, based on the reduc-
tion of activated phosphoforms of Lck, ZAP-70, and LAT.
Activation of the tyrosine kinase cascade by 5 min was fo-
cused in the periphery of the IS, even after the first wave of
microclusters had moved to the cSMAC. Sensitive TIRFM
imaging revealed that new TCR clusters form in the periph-
ery by 5 min, after the cSMAC is formed. The formation of
microclusters was not blocked by 
 
 
 
95% inhibition of
pLck
 
394
 
 production and total inhibition of Ca
 
2
 
 
 
 increase and
LFA-1 activation by PP2, but was blocked completely by
depletion of actin filaments with latrunculin A.
These results suggest that microclusters may be primary,
actin-dependent scaffolds for signaling. The role of actin in
microcluster formation parallels its long established role in
TCR signaling (28). The classic pathway for TCR regula-
tion of actin requires an intact tyrosine kinase cascade that is
initiated by Src family kinases (29–31). TCR microclusters
are highly resistant to inhibition by PP2. However, the mi-
croclusters that formed in the presence of PP2 contained de-
tectable pLck
 
394
 
 and pZAP
 
319
 
; further work is needed to de-
termine if different mechanisms for actin regulation are
involved in microcluster formation compared with down-
stream signals.
The supported planar bilayer system combines advan-
tages of anti-CD3–coated glass and APCs. The ability to
apply TIRFM is an advantage of anti-CD3–coated glass
and glass-supported planar bilayers (32, 33). The planar bi-
layer system is more physiologic than anti-CD3–coated
surfaces in that defined cell adhesion molecules and agonist
Figure 4. Effect of inhibition of Src family kinases and actin poly-
merization on TCR microclusters. Alexa546-H57 Fab–labeled AND TCR 
Tg T cells were incubated on bilayers containing ICAM-1 and MHCp after 
treatment by relevant drug vehicles, 10  M PP2 or 1  M latrunculin A. 
These concentrations inhibit Src family kinases and actin polymerization, 
respectively,  90% in intact cells. In each case, cells were treated with the 
drugs for 1 h before introduction to the planar bilayers. (A) TIRFM time 
course of TCR clustering (top) in the presence of inhibitory concentration 
of PP2. Activity of PP2 was verified by lack of robust Ca2  elevation (bottom). 
(B) Reduction of pLck394 in TCR microclusters in the presence of 100  M 
PP2 versus DMSO vehicle at 5 min. (wide-field images) Similar results were 
obtained by TIRFM. (C) Wide-field image of unlabeled AND T cell blasts on 
bilayers containing Oregon Green I-Ek (green in overlay) and Cy5 ICAM-1 
(red in overlay) after cell treatment with vehicle, 10  M PP2 or 1  M 
latrunculin A, for 1 h before exposure to the bilayer for 1 h. The IRM image 
shows the contact area in darker gray. Individual fluorescence images are 
as indicated. The percent adhesion is indicted in the column adjacent to 
the images. Representative of three experiments each. 
JEM VOL. 202, October 17, 2005
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MHCp are incorporated—and when anchored to lipids—
are laterally mobile as on APCs (34). Mobility of the bilayer
allows formation of SMACs (2, 5). Although single MHCp
can be counted in snapshots of the T cell–APC interface
(35), the supported planar bilayers can be used to track sin-
gle molecules over time (32, 33). The planar bilayer system
is less physiologic than APCs, because the number of APC
components incorporated into the bilayers is limited, the
diffusion coefficients are faster in the supported bilayer than
in cellular systems, and the surface is rigidly two-dimen-
sional, unlike three-dimensional APC membranes. This
property of forcing the interface into two dimensions may
promote organization of the IS into SMACs more readily
than three-dimensional APCs (8). We used high densities
of agonist MHCp compared with the limiting case of 
 
 
 
10
MHCp in the IS defined by T cell–APC studies (35).
However, in the latter case, thousands of self-MHCp also
contribute to the activation process and make it likely that
microclusters with many TCRs contribute (35, 36). Our
study used the supported planar bilayer model to advance
the general understanding of TCR microclusters—structures
that are well documented in T cell–APC systems—by taking
advantage of TIRFM and the ability to manipulate agonist
MHCp density over a wider range than is possible with APCs.
Our finding extends those obtained with anti-CD3 sub-
strates that show signaling by small TCR clusters in seconds
that are resistant to PP2, but are dependent upon actin (12).
It was not known if these characteristics were related to anti-
CD3 or intrinsic to TCR recognition of physiologic ligands.
The stimulation of normal T cells with mobile MHCp re-
sults in a highly ordered signaling structure in which the
cSMAC has relatively low tyrosine kinase activation and the
pSMAC contains foci of efficient tyrosine kinase activation.
These distinct compartments have not been documented
with anti-CD3 on glass (12, 14, 32). Our results with physi-
ologic affinity MHCp reveal that there is an active process of
MHC microcluster formation that precedes Ca
 
2
 
 
 
 elevation
and is dependent upon f-actin. Probing the mechanism of
f-actin–dependent cluster formation may lead to new ap-
proaches to control of T cell signaling through manipulation
of the microcluster scaffold.
 
MATERIALS AND METHODS
 
Materials.
 
The H57 (anti-TCR
 
 
 
) hybridoma was obtained from Ameri-
can Type Culture Collection. The acetoxymethyl ester form of the calcium
sensitive, cell leakage resistant dye Fluo-LOJO, was purchased from Teflabs.
All other reagents were obtained from Sigma-Aldrich. PP2 (4-amino-
5-[4-chlorophenyl]-7-[t-butyl]pryazolo[3,4-d]pyrimidine) was purchased
from Calbiochem.
 
Mice and cell culture.
 
B10.Cg-Tg (TcrAND) 53Hed/J (B10.AND),
TCR transgenic mice were purchased from The Jackson Laboratory and
were crossed to B10.Br mice.
AND TCR Tg spleen cells were activated in DMEM (Invitrogen)
with 10% FBS (Hyclone) using 1 
 
 
 
M MCC peptide (MCC88-103). At 48 h,
the cells were washed twice in complete medium and were plated at 10
 
6
 
cells/ml with 50 U/ml of rIL-2. The cells were replenished with fresh me-
dia and IL-2 every 2 d. Experiments were performed on T cells between 6
and 15 d after activation.
 
Bilayers.
 
Glass-supported dioleoylphosphatidylcholine bilayers incorporat-
ing GPI-anchored forms of unlabeled I-E
 
k
 
 (200 molecules/
 
 
 
m
 
2
 
 total) and
unlabeled or Cy5–ICAM-1 (300 molecules/
 
 
 
m
 
2
 
) were prepared in
Bioptechs flow cell (5). The bilayers were loaded with 100 
 
 
 
M MCC88-
103 peptide (5).
 
Phosphoprotein staining.
 
T cells were fixed with 2% formaldehyde for
12 min, permeabilized with 0.05% Triton X-100 for 1 min, blocked with 5%
casein for 20 min, and stained with anti phospho–ZAP-70
 
319
 
 (Cell Signaling),
anti–phospho-LAT
 
191
 
 (Upstate Biotechnology), and anti phospho-Lck
 
394
 
 spe-
cific affinity purified rabbit antibody (A. Shaw, Washington University
School of Medicine, St. Louis, MO). An Alexa Fluor-488 goat anti–rabbit
F(ab
 
 
 
)
 
2
 
 (Invitrogen) was used as secondary antibody.
 
Microscopy.
 
All microscopy was performed on an automated microscope
with an Olympus TIRFM module (17) and a Hamamatsu USA Orca-ER
cooled CCD camera. The hardware on the microscope was controlled us-
ing IPLAB software (Scanalytics) on a PowerMac G4 Macintosh computer.
Solamere Technology provided integration support.
 
Imaging of TCR and phosphoprotein staining.
 
AND T cells were
suspended in Hepes buffered saline supplemented with 5 mM glucose, 2 mM
MgCl2, 1 mM CaCl2, and 1% human serum albumin (HBS/HSA), and were
labeled with 10  g/ml Alexa488 or 546 conjugated H57 Fab. The labeled
cells were made to interact with the bilayers at 37 C. For TIRFM, the Fab
was present continuously during imaging. In wide-field or TIRFM mode,
images were exposed for 1–2 s, at a resolution of 0.11  m per pixel using the
60  1.45 N.A. objective. Images were inspected using Metamorph (Molecu-
lar Devices). Quantification of the signaling efficiency, based upon phospho-
protein and TCR intensities, was performed in IPLAB. Colocalization by
area was analyzed using this function of Volocity (Improvision).
Estimation of initial microcluster size. H57 binding sites on T cell blasts
were determined by flow cytometry with fluorescein calibration beads
(Bangs Labs) to be 42,000 per cell (140 per  m2). Microclusters were two
times the average intensity of MHCp of 50 molecules/ m2. Therefore, 140
TCRs were present in 0.35–0.5  m2 area.
Calcium measurements. AND T cells were labeled with 3  M of Fluo-
LOJO (KCa2    440 nM). Images with ionomycin in normal and no Ca2 
buffers were used to set minimum and maximum levels for display of rela-
tive Fluo-LOJO fluorescence. Basal and activation associated ranges were
defined based on measurements on cells on ICAM-1 (basal range) or
ICAM-1 plus agonist MHCp (activated range).
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